POA Leadership
The Caris Precision Oncology Alliance™ (POA) Executive Committee establishes appropriate molecular testing principles to serve as guidelines for the consistent application of tumor profiling across the oncology community.
POA Leadership
Executive Committee
The Executive Committee facilitates collaborative research studies across the POA and coordinates outcome tracking initiatives to generate and document additional medical evidence for the appropriate use and impact of profiling. The Executive Committee of the POA serves as a resource to Caris leadership helping to drive research strategy and direction.
Chadi Nabhan, MD, MBA, FACP
Chairman
Precision Oncology Alliance
John L. Marshall, MD
Chief, Hematology and Oncology
Georgetown University
Elisabeth Heath, MD
Associate Center Director
Translational Sciences
Karmanos Cancer Institute
Heinz-Josef Lenz, MD, FACP
Associate Director for Clinical Research
USC Norris Comprehensive Cancer Center
Thomas Herzog, MD
Professor of OB-GYN
Deputy Director
University of Cincinnati Cancer Institute
Wafik El-Deiry, MD, PhD, FACP
Associate Dean for Oncologic Sciences
Brown University
Marcia Cruz-Correa, MD, PhD
Executive Director
University of Puerto Rico
Ruben Mesa, MD
Director
UT Health San Antonio
MD Anderson Center
Sagar Lonial, MD, FACP
Chief Medical Officer
Professor and Chair
Emory University
Joann Sweasy, PhD
Director, Cancer Center
Associate Director, Basic Sciences
University of Arizona
Edith Mitchell, MD
Clinical Professor
Program Leader, Gastrointestinal Oncology
Jefferson Health
Manmeet Ahluwalia, MD, MBA
Chief, Solid Tumor Medical Oncology
Deputy Director, Chief Scientific Officer
Miami Cancer Institute